Jiangsu Nanfang Medical Co., Ltd. (603880.SS)
CNY 4.92
(-2.38%)
CNY 4.92
(-2.38%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -76.01 Million CNY | -37.14% |
| 2022 | 28.28 Million CNY | 15.45% |
| 2021 | 12.86 Million CNY | -80.61% |
| 2020 | 132.93 Million CNY | 218.81% |
| 2019 | 49.85 Million CNY | -13.2% |
| 2018 | 64.13 Million CNY | -4.12% |
| 2017 | 69.38 Million CNY | -14.94% |
| 2016 | 79.21 Million CNY | 2.17% |
| 2015 | 76.06 Million CNY | -6.96% |
| 2014 | 80.41 Million CNY | 8.01% |
| 2013 | 79.44 Million CNY | 54.97% |
| 2012 | 53.71 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -15.45 Million CNY | -172.63% |
| 2024 Q1 | -426.1 Thousand CNY | 111.59% |
| 2024 Q2 | 17.07 Million CNY | 16.33% |
| 2023 Q2 | 11.98 Million CNY | 322.89% |
| 2023 Q1 | 2.83 Million CNY | 115.22% |
| 2023 FY | - CNY | -37.14% |
| 2023 Q4 | -43.74 Million CNY | -25886.7% |
| 2023 Q3 | 169.65 Thousand CNY | -98.58% |
| 2022 Q3 | 2.23 Million CNY | -51.69% |
| 2022 Q2 | 4.63 Million CNY | -59.18% |
| 2022 Q1 | 11.34 Million CNY | 196.57% |
| 2022 FY | - CNY | 15.45% |
| 2022 Q4 | -18.61 Million CNY | -931.66% |
| 2021 Q4 | -11.75 Million CNY | -363.43% |
| 2021 Q3 | 4.46 Million CNY | 101.06% |
| 2021 Q1 | 11.73 Million CNY | -78.27% |
| 2021 FY | - CNY | -80.61% |
| 2021 Q2 | 2.21 Million CNY | -81.09% |
| 2020 FY | - CNY | 218.81% |
| 2020 Q4 | 53.97 Million CNY | 481.28% |
| 2020 Q1 | 13.4 Million CNY | 54.11% |
| 2020 Q2 | 87.1 Million CNY | 549.58% |
| 2020 Q3 | 9.28 Million CNY | -89.34% |
| 2019 Q3 | 13.29 Million CNY | -9.28% |
| 2019 FY | - CNY | -13.2% |
| 2019 Q4 | 8.7 Million CNY | -34.56% |
| 2019 Q1 | 8.3 Million CNY | 42.89% |
| 2019 Q2 | 14.65 Million CNY | 76.54% |
| 2018 Q3 | 16.36 Million CNY | -4.81% |
| 2018 FY | - CNY | -4.12% |
| 2018 Q4 | 5.8 Million CNY | -64.49% |
| 2018 Q2 | 17.18 Million CNY | 5.77% |
| 2018 Q1 | 16.24 Million CNY | 136.56% |
| 2017 FY | - CNY | -14.94% |
| 2017 Q1 | 12.54 Million CNY | -23.38% |
| 2017 Q2 | 226.68 Million CNY | 1706.28% |
| 2017 Q3 | 14.89 Million CNY | -93.43% |
| 2017 Q4 | 6.86 Million CNY | -53.87% |
| 2016 FY | - CNY | 2.17% |
| 2016 Q4 | 16.37 Million CNY | 2.9% |
| 2016 Q3 | 15.91 Million CNY | -8.62% |
| 2016 Q2 | 17.41 Million CNY | 0.0% |
| 2016 Q1 | 17.41 Million CNY | 0.0% |
| 2015 FY | - CNY | -6.96% |
| 2014 FY | - CNY | 8.01% |
| 2013 FY | - CNY | 54.97% |
| 2012 FY | - CNY | 0.0% |